The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors.
Open accessAbstract
Hypersecretion of luteinizing hormone (LH) is implicated in infertility and miscarriages in women. A lack of animal models has limited progress in determining the mechanisms of LH toxicity. We have recently generated transgenic mice expressing a chimeric LH beta subunit (LH beta) in gonadotropes. The LH beta chimera contains the C-terminal peptide of the human chorionic gonadotropin beta subunit. Addition of this peptide to bovine LH beta resulted in a hormone with a longer half-life. Furthermore, targeted expression of the LH beta chimera led to elevated LH levels and infertility in female transgenics. These mice ovulated infrequently, maintained a prolonged luteal phase, and developed pathologic ovarian changes such as cyst formation, marked enlargement of ovaries, and granulosa cell tumors. Testosterone and estradiol levels were increased compared to nontransgenic littermates. An unusual extragonadal phenotype was also observed: transgenic females developed hydronephropathy and pyelonephritis. The pathology observed demonstrates a direct association between abnormal secretion of LH and infertility and underscores the utility of the transgenic model for studying how excess LH leads to cyst formation, ovarian tumorigenesis, and infertility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lubahn, D. B., Moyer, J. S., Golding, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11162 · Cited by 1,898
Crystal structure of human chorionic gonadotropin
Lapthorn, A. J., Harris, D. C., Littlejohn, A., Lustbader, J. W., Canfield, R. E., Machin, K. J., Morgan, F. J., & Isaacs, N. W. (1994) · Nature · doi:10.1038/369455a0 · Cited by 936
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Vaitukaitis, J. L., Braunstein, G. D., & Ross, G. T. (1972) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(72)90553-4 · Cited by 891
α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice
Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., & Bradley, A. (1992) · Nature · doi:10.1038/360313a0 · Cited by 890
Radioimmunoassay for Rat Luteinizing Hormone with Antiovine LH Serum and Ovine LH-131I
Niswender, G. D., Midgley, A. R., Monroe, S. E., & Reichert, L. E. (1968) · Experimental Biology and Medicine · doi:10.3181/00379727-128-33129 · Cited by 862
Simmons, D. M., Voss, J. W., Ingraham, H. A., Holloway, J. M., Broide, R. S., Rosenfeld, M. G., & Swanson, L. W. (1990) · Genes & Development · doi:10.1101/gad.4.5.695 · Cited by 634
POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
FRANKS, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 526
Hypersecretion of luteinising hormone, infertility, and miscarriage
Regan, L., Owen, E. J., & Jacobs, H. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)92765-a · Cited by 450
Wagner, T. E., Hoppe, P. C., Jollick, J. D., Scholl, D. R., Hodinka, R. L., & Gault, J. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6376 · Cited by 319
Self-citationFares, F. A., Suganuma, N., Nishimori, K., LaPolt, P. S., Hsueh, A. J., & Boime, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4304 · Cited by 285
On the Paradox of Insulin-Induced Hyperandrogenism in Insulin-Resistant States
PORETSKY, L. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-1-3 · Cited by 262
Karsch, F. J. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002053 · Cited by 170
Shoham, Z., Jacobs, H. S., & Insler, V. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55968-8 · Cited by 158
Ovarian stimulation and granulosa-cell tumour
Willemsen, W. N. P., Kruitwagen, R. F. P. M., Bastiaans, L. A., Rolland, R., & Hanselaar, A. G. J. M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91071-s · Cited by 137
Targeted Ablation of Pituitary Gonadotropes in Transgenic Mice
Kendall, S. K., Saunders, T. L., Jin, L. G., Lloyd, R. V., Glodé, L. M., Nett, T. M., Keri, R. A., Nilson, J. H., & Camper, S. A. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-2025 · Cited by 116
Self-citationKumar, T. R., Fairchild-Huntress, V., & Low, M. J. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.1.1738375 · Cited by 60
Polycystic ovarian disease: current concepts of pathophysiology and therapy
Wallach, E. E., & Coney, P. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48189-6 · Cited by 60
Hamernik, D. L., Keri, R. A., Clay, C. M., Clay, J. N., Sherman, G. B., Sawyer, H. R., Nett, T. M., & Nilson, J. H. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.10.1280329 · Cited by 53
Self-citation
Cited by
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Metadata
- Authors
- Risma, K. A., Clay, C. M., Nett, T. M., Wagner, T., Yun, J., & Nilson, J. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-02-28
- Volume
- 92
- Issue
- 5
- Pages
- 1322-1326
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2030462220
- Cited by
- 328
- References
- 19
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.